← Leaderboards
Radhika Agarwal
Harvard Medical School
$124,624
Attributed
$124,624
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51K · FY2019–21$100K$75K$50K$25K$0
'19
'20
'21
Funding mix
By agency
NIH$124,624 · 1
By mechanism
F30$124,624 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Christine E. Seidman$18,595,172
- Jonathan G Seidman$34,587,463
- Arlene H Sharpe$68,359,602
- Christopher S Chen$23,331,537
- Alexa T. McCray$12,243,503
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAttenuatedBiologyCardiacCardiac MyocytesCardiomyopathiesCause Of DeathCell NucleusContractsCoronary ArteriosclerosisExome SequencingFunctional DisorderGenesGeneticGenetic VariantHeartHeart FailureHypertensionImpairmentInduced Pluripotent Stem CellInheritedInsightLeadLoss Of Function Mutation
Grant awards (3)
Characterizing the mechanism of loss-of-function mutations in ALPK3 in the pathogenesis of cardiomyopathy$51,036
F30 · FY2021 · HL · contact PI
Characterizing the mechanism of loss-of-function mutations in ALPK3 in the pathogenesis of cardiomyopathy$37,046
F30 · FY2020 · HL · contact PI
Characterizing the mechanism of loss-of-function mutations in ALPK3 in the pathogenesis of cardiomyopathy$36,542
F30 · FY2019 · HL · contact PI